Performance of Primary Angioplasty for STEMI during the COVID-19 Outbreak
Abstract There has been concern whether the declining cases of ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) outbreak associate with primary angioplasty performance. We assessed the performance of primary angioplasty in a tertiary care hospital in...
Saved in:
Published in | The International journal of angiology Vol. 30; no. 2; pp. 148 - 154 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
Thieme Medical Publishers, Inc
01.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract
There has been concern whether the declining cases of ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) outbreak associate with primary angioplasty performance.
We assessed the performance of primary angioplasty in a tertiary care hospital in Jakarta, Indonesia, by comparing the door-to-device (DTD) time and thrombolysis in myocardial infarction (TIMI) flow after angioplasty between two periods of admission: during the outbreak of COVID-19 (March 1 to May 31, 2020) and before the outbreak (March 1, to May 31, 2019).
Overall, there was a relative reduction of 44% for STEMI admission during the outbreak (
n
= 116) compared with before the outbreak (
N
= 208). Compared with before the outbreak period (
n
= 141), STEMI patients who admitted during the outbreak and received primary angioplasty (
n
= 70) had similar median symptom onset-to-angioplasty center admission (360 minutes for each group), similar to radial access uptake (90 vs. 89.4%,
p
= 0.88) and left anterior descending infarct-related artery (54.3 vs. 58.9%,
p
= 0.52). The median DTD time and total ischemia time were longer (104 vs. 81 minutes,
p
< 0.001, and 475.5 vs. 449 minutes,
p
= 0.43, respectively). However, the final achievement of TIMI 3 flow was similar (87.1 vs. 87.2%), and so was the in-hospital mortality (5.7 vs. 7.8%).
During the COVID-19 outbreak, we found a longer DTD time for primary angioplasty, but the achievement of final TIMI 3 flow and in-hospital mortality were similar as compared with before the outbreak. Thus, primary angioplasty should remain the standard of care for STEMI during the COVID-19 outbreak. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1061-1711 1615-5939 |
DOI: | 10.1055/s-0041-1727133 |